FDA clears Outset Medical’s TabloCart with prefiltration for enhanced dialysis treatment
Outset Medical, Inc., a leader in innovative medical technology, has announced that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance for its new product, TabloCart with prefiltration. This accessory is designed to enhance the functionality of the Tablo Hemodialysis System, already known for its revolutionary approach to dialysis by reducing the procedure’s […]